Microdermis launches Provodine in award-winning packaging

Ampac’s seven-layer laminate provides package integrity, barrier, portability, and dispensing functionality for this next-generation infection control product.

Next-generation infection control product Provodine cream includes aggressive chemical compounds that were addressed by an award-winning seven-layer flexible packaging structure for the product’s 3-mL packette shown here.
Next-generation infection control product Provodine cream includes aggressive chemical compounds that were addressed by an award-winning seven-layer flexible packaging structure for the product’s 3-mL packette shown here.

A laminated flexible film structure from Ampac proved essential in helping lifesciences company Microdermis Corp. launch its flagship product Provodine®, an infection-control product to be initially targeted to the U.S. military.

The proprietary structure earned a 2015 AmeriStar Award in the Drug & Pharmaceutical category.

Princeton, NJ-based Microdermis Corp. is a lifesciences company that focuses on the development of novel products based on its patented Amidermal® technology.

Harry Corless, VP of Technical Operations for Microdermis, notes, “Provodine is a cream targeted initially only in the U.S., but soon globally starting in South America. Beginning with the U.S. military, it will be sold into the professional market, to hospitals, clinics, and long-term care facilities.”

Provodine is sold presently in 3-mL packettes/sachets, 4-oz bottles, and 16-oz bottles with pumps, with additional SKUs planned for next year. For this article, the focus is on the product’s fast-growing packettes.

Microdermis refers to the product as a next-generation professional antiseptic that meets or exceeds FDA requirements for use as a surgical scrub, pre-operative skin preparation, healthcare personnel hand wash, and first aid antiseptic.

Provodine uses Microdermis’ Amidermal technology for enhanced kill strength of dangerous microbes. Provodine has been tested against most category 1 (deadly/weaponized/no known cures) pathogens and kills them all within 30 seconds of exposure time, even after 12 hours of dry time on exposed skin.

There are currently no known resistant strains to Provodine, useful for deployment in challenging environments with an unknown mix of infection sources, such as in military field hospitals, and with globally deployed NGO (non-governmental organization) personnel.

Provodine uses Povidone-Iodine and contains a proprietary blend of skin moisturizers and humectants that nourish and rebuild the skin, eliminating dryness and cracking, which are not only uncomfortable, but also create portals for microbes.

Corless says, “Provodine has a broad spectrum of kill, provides increased longevity of protection, and is more gentle to the skin than other competitive products in the market today.”

Considerable packaging requirements

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report